Interventional/Surgery

Academic Series

Sort by

Page

Showing 1 - 1 of 1 documents.

Academic series

Duke Clinical Medicine Series

2 COMMENTS - Mar 1, 2008 15:50 EST

A series of interactive, evidence-based programs designed to improve the care of patients requiring cardiac catheterization and interventions

Previews

Featured programs

Inside: Interventional/Surgery

Interventional/Surgery

TCT 2008: What Was Hot?

Nov 6, 2008 10:10 EST

HORIZONS-AMI, SORT-OUT III, FAME, SYNTAX revisited... What were the big stories at TCT 2008? Drs Popma and Cohen break it down.

Interventional/Surgery

Bifurcation Stenting: Should You Keep it Simple?

4 COMMENTS - Nov 4, 2008 14:24 EST

Provisional T-stenting, crush, or culotte? Which is the best way to tackle bifurcation lesions? Dr Hildick-Smith presents an overview including the results of his TCT 2008 late-breaking BBC-ONE trial.

Interventional/Surgery

Optimal Acute Myocardial Infarction Management Redefined

Dec 1, 2008 10:30 EST

Can drug-eluting stents now be considered the standard of care in patients with STEMI undergoing PCI? Can target lesion revascularization be reduced further? What about bleeding? Please join Drs Stone, White, and Harrington as they tackle these and other pressing questions in the treatment of AMI.

Interventional/Surgery

Where Has the Boundary Between PCI and CABG Moved?

5 COMMENTS - Oct 30, 2008 10:06 EDT

Will SYNTAX results mean more patients with complex lesions now receive DES? Join our international panel of experts, Drs Serruys, Mohr, Beatt, and Smith as they discuss optimal management of patients with complex cardiovascular lesions.

Heart failure

What Happened at AHA 2008? Mayo Clinic Perspective

Nov 26, 2008 13:20 EST

In our first program Drs Gibbons, Holmes, and Simari discuss cell therapy and the latest trials in intervention. Our second program features Drs Gibbons, Ackerman, and Redfield discuss personalized genomics and heart failure.

Clinical cardiology

Antiplatelet Therapy for the Prevention of Stroke in AF

Nov 26, 2008 09:53 EST

Warfarin remains the cornerstone of stroke prevention in patients with AF. However, many patients are unable or unwilling to take it. Could antiplatelet therapy fill this gap? How might investigational anticoagulants change the playing field? Dr Naccarelli leads a panel discussion with Drs Connolly and Camm.

| | | | | | | | | |

We comply with the HONcode standard
for trustworthy health information: verify here.

	All ACS patients
	High-risk ACS only
	Delayed for all